NCT04985851 2023-12-01
To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.
Shanghai Chest Hospital
Phase NA Unknown
Clinical Trials
5 trialsNCT04851132 2021-06-22
Radiotherapy Plus Durvalumab in Elderly Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase NA Unknown
NCT04517227 2021-05-03
The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD)
Fudan University
Phase NA Unknown
NCT04443322 2020-09-22
Dulect2020-1
RenJi Hospital
Phase NA Unknown
NCT04444193 2020-06-23
Dulect2020-2
Shanghai First Maternity and Infant Hospital
Phase NA Unknown